TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 122 filers reported holding TURNING POINT THERAPEUTICS I in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $11,925,000 | -48.7% | 250,000 | -28.6% | 0.32% | -37.7% |
| Q3 2021 | $23,251,000 | -14.9% | 350,000 | 0.0% | 0.52% | -6.1% |
| Q2 2021 | $27,307,000 | -7.7% | 350,000 | +11.9% | 0.55% | +5.9% |
| Q1 2021 | $29,578,000 | -30.6% | 312,700 | -10.7% | 0.52% | -42.9% |
| Q4 2020 | $42,648,000 | +50.2% | 350,000 | +7.7% | 0.92% | +32.9% |
| Q3 2020 | $28,392,000 | +25.6% | 325,000 | -7.1% | 0.69% | +8.8% |
| Q2 2020 | $22,607,000 | +68.7% | 350,000 | +16.7% | 0.63% | +11.8% |
| Q1 2020 | $13,398,000 | -28.3% | 300,000 | 0.0% | 0.57% | -21.6% |
| Q4 2019 | $18,687,000 | +24.2% | 300,000 | -25.0% | 0.72% | +19.7% |
| Q3 2019 | $15,040,000 | +84.8% | 400,000 | +100.0% | 0.60% | +83.3% |
| Q2 2019 | $8,140,000 | – | 200,000 | – | 0.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,750,000 | $260,122,000 | 5.80% |
| Burrage Capital Management LLC | 72,164 | $6,826,000 | 5.53% |
| Consonance Capital Management LP | 450,396 | $42,603,000 | 4.54% |
| MPM BioImpact LLC | 269,186 | $25,462,000 | 3.20% |
| Orbimed Advisors | 2,361,327 | $223,358,000 | 2.09% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 81,541 | $7,711,000 | 2.04% |
| SECTORAL ASSET MANAGEMENT INC | 257,879 | $24,393,000 | 1.85% |
| Nicholas Investment Partners, LP | 218,847 | $20,701,000 | 1.44% |
| Logos Global Management LP | 140,000 | $13,243,000 | 1.29% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 16,741 | $1,584,000 | 0.86% |